Clinical Trials in Phoenix

Showing 4221-4240 of 12,085 trials

Ambispective Clinical Evaluation of Sophono™

NCT03143257

Study to accumulate post-market clinical evidence for the safety and effectiveness of the Sophono Alpha 2 and Alpha 2 Maximum Power Output (MPO) systems in subjects diagnosed with conductive hearing loss, single-sided deafness and mixed hearing loss who currently have or have had the Sophono implant.

Conductive Hearing LossSingle-Sided DeafnessMixed Hearing Loss

Medtronic Surgical Technologies71 participantsStarted Jun 2017

Phoenix, Arizona, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +3 more locations

COMPLETEDPhase 1< 1 mile

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

NCT02493530

This is a Phase 1, open-label, study of TGR-1202, a PI3K delta inhibitor, administered together with ruxolitinib in patients with myeloproliferative neoplasms (specifically: polycythemia vera, primary myelofibrosis, PPV-MF or PET-MF) and MDS/MPN.

MyelofibrosisPolycythemia Vera

Vanderbilt-Ingram Cancer Center60 participantsStarted Jul 2015

Phoenix, Arizona, United States • Aurora, Colorado, United States • Nashville, Tennessee, United States +2 more locations

Ambispective Clinical Evaluation of Sophono™

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Find Trials by Condition in Phoenix

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT